This is from the Hervaxx already used in earlier trial... so benefit is... 42% OSS - see highlight from study earlier.
However this study is about linking the tumour reaction with production of antibodies.
In other words this shows/proves that it is indeed Hervaxx that is doing the shrinking of tumours, not some other weird combination or setup.
Ann: HER-Vaxx induced antibodies correlated with tumour reduction, page-33
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.7¢ |
Change
0.001(1.79%) |
Mkt cap ! $417.2M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 5.8¢ | 5.6¢ | $158.5K | 2.771M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 1869756 | 5.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.8¢ | 2013643 | 25 |
View Market Depth
| Last trade - 11.41am 20/06/2024 (20 minute delay) ? |
| IMU (ASX) Chart |